TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA TAHO Pharma has submitted a New Drug Application for TAH3311, an innovative Apixaban Oral Dissolving Film, to the U.S. FDA. This product aims to enhance anticoagulant therapy significantly.

TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA #Taiwan #Taipei #TAH3311 #Apixaban #TAHO_Pharma